Background More than 10 years have elapsed since human papillomavirus (HPV) vaccination
was implemented. We did a systematic review and meta-analysis of the population-level …

Background The extent of cross-protection is a key element in the choice of human
papillomavirus (HPV) vaccine to use in vaccination programmes. We compared the cross-protective …

Background The WHO Director-General has issued a call for action to eliminate cervical
cancer as a public health problem. To help inform global efforts, we modelled potential human …

The unique characteristic of vaccination is that it not only reduces the incidence of disease in
those immunized but also indirectly protects nonvaccinated susceptibles against infection (…

Background Human papillomavirus (HPV) vaccination programmes were first implemented
in several countries worldwide in 2007. We did a systematic review and meta-analysis to …

Background Introduction of human papillomavirus (HPV) vaccination in settings with the
highest burden of HPV is not universal, partly because of the absence of quantitative estimates …

Background The past two decades have seen expansion of childhood vaccination programmes
in low-income and middle-income countries (LMICs). We quantify the health impact of …

Background WHO is developing a global strategy towards eliminating cervical cancer as a
public health problem, which proposes an elimination threshold of four cases per 100 000 …

Background: Vaccination against herpes zoster is being considered in many countries. We
conducted a multicentre prospective study to describe the impact of herpes zoster and …

Background Modelling studies have been widely used to inform human papillomavirus (HPV)
vaccination policy decisions; however, many models exist and it is not known whether they …